Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Kapa Baits for metagenomic sequencing

U.S. Department Of Health And Human Services·Maryland

Kapa Baits for metagenomic sequencing

Closes 3/19/2026$10k – $30kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The purpose of this requirement is to procure myBaits Custom 480K hybridization capture reagents equivalent to sixty-four (64) enrichment reactions to support targeted metagenomic sequencing for the detection and identification of arthropod contaminants in food products. The procurement is for reagents only, as sequencing equipment and laboratory instrumentation are already available. • The required reagents are myBaits Custom hybridization capture reagents equivalent to sixty-four (64) enrichment reactions. • The reagents will be used for targeted metagenomic DNA sequencing to detect and identify arthropod contaminants in food products. • The procurement is being conducted in accordance with FAR Part 13, Simplified Acquisition Procedures. • Interested parties that believe they can provide an equivalent product meeting the Government’s technical requirements may submit capability statements.

Attached files

Contact

Erika Crawford(Contract Specialist)

[email protected]

(301) 796-0298

Key dates

Opened
3/12/2026
Questions due
3/19/2026
Closes
3/19/2026

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
325414
Solicitation №
HFP-2026-133128

Budget estimate

$10,000 – $30,000

The budget for this opportunity is likely to be moderate, given the specialized nature of the reagents being procured. The cost of the myBaits Custom hybridization capture reagents will depend on the manufacturer, the quantity required, and the complexity of the project. Based on industry standards, the cost of similar reagents can range from $5,000 to $50,000 or more, depending on the specifics of the project. Therefore, a reasonable estimate for the budget for this opportunity could be between $10,000 and $30,000.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 63%

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Department Of Health And Human Services·Maryland

63% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

62% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

62% match

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Closes 1/11/2027Opened 1/20/2026

U.S. National Institutes of Health·United States of America

62% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. National Institutes of Health·United States of America

61% match

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

Closes 11/22/2028Opened 6/16/2025

U.S. National Institutes of Health·United States of America

61% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

60% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

60% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

60% match

Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

Closes 11/10/2026Opened 3/3/2026

U.S. National Institutes of Health·United States of America

60% match

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Institutes of Health·United States of America

60% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

60% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

59% match

Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Closes 1/8/2027Opened 5/14/2025

U.S. National Institutes of Health·United States of America

59% match

Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)

Closes 2/26/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

59% match

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

59% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

59% match

Research on the Ethical, Legal and Social Implications (ELSI) of Genomics

Closes 2/15/2027Opened 6/3/2026

U.S. National Institutes of Health·United States of America

58% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

58% match

RNomics Technology Enhancement Centers

Closes 1/31/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

58% match

R3PEATS Grassroots Rigor Projects: Individual Metascience and Individual Laboratory Capacity-Building (RP1)

Closes 9/30/2027Opened 9/11/2026